Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Schmid

Showing results (481-490 of 549) with videos related to

Pageof 55
Sort By:
Frontiers in Allergy|June 30, 2022
White Paper on European Patient Needs and Suggestions on Chronic Type 2 Inflammation of Airways and Skin by EUFOREALouise De Prins, Ulrike Raap, Tara Mueller, et al.
The Journal of Allergy and Clinical Immunology|November 1, 2011
A genome-wide meta-analysis of genetic variants associated with allergic rhinitis and grass sensitization and their interaction with birth orderAdaikalavan Ramasamy, Ivan Curjuric, Lachlan J Coin, et al.
The New England Journal of Medicine|September 16, 2024
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast CancerPeter Schmid, Javier Cortes, Rebecca Dent, et al.
The New England Journal of Medicine|October 30, 2024
Inavolisib-Based Therapy in <i>PIK3CA</i>-Mutated Advanced Breast CancerNicholas C Turner, Seock-Ah Im, Cristina Saura, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 31, 2023
S3 guideline Atopic dermatitis: Part 2 - Systemic treatmentThomas Werfel, Annice Heratizadeh, Werner Aberer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 3, 2024
S3 Guideline Atopic dermatitis: Part 1 - General aspects, topical and non-drug therapies, special patient groupsThomas Werfel, Annice Heratizadeh, Werner Aberer, et al.
Human Molecular Genetics|August 11, 2011
LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in miceMartin C Herzig, Carine Kolly, Elke Persohn, et al.
JAMA Oncology|October 7, 2021
Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor-Positive, ERBB2-Negative Advanced Breast Cancer: A Randomized Clinical TrialAntonio Llombart-Cussac, José Manuel Pérez-García, Meritxell Bellet, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2021
Pembrolizumab plus eribulin in hormone-receptor-positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase Ⅱ trialJosé M Pérez-García, Antonio Llombart-Cussac, María G Cortés, et al.
Breast (Edinburgh, Scotland)|June 16, 2024
Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancerSerena Di Cosimo, José Manuel Pérez-García, Meritxell Bellet, et al.
Pageof 55

Showing results (481-490 of 549) with videos related to

Sort By:
Pageof 55
Frontiers in Allergy|June 30, 2022
White Paper on European Patient Needs and Suggestions on Chronic Type 2 Inflammation of Airways and Skin by EUFOREALouise De Prins, Ulrike Raap, Tara Mueller, et al.
The Journal of Allergy and Clinical Immunology|November 1, 2011
A genome-wide meta-analysis of genetic variants associated with allergic rhinitis and grass sensitization and their interaction with birth orderAdaikalavan Ramasamy, Ivan Curjuric, Lachlan J Coin, et al.
The New England Journal of Medicine|September 16, 2024
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast CancerPeter Schmid, Javier Cortes, Rebecca Dent, et al.
The New England Journal of Medicine|October 30, 2024
Inavolisib-Based Therapy in <i>PIK3CA</i>-Mutated Advanced Breast CancerNicholas C Turner, Seock-Ah Im, Cristina Saura, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 31, 2023
S3 guideline Atopic dermatitis: Part 2 - Systemic treatmentThomas Werfel, Annice Heratizadeh, Werner Aberer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 3, 2024
S3 Guideline Atopic dermatitis: Part 1 - General aspects, topical and non-drug therapies, special patient groupsThomas Werfel, Annice Heratizadeh, Werner Aberer, et al.
Human Molecular Genetics|August 11, 2011
LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in miceMartin C Herzig, Carine Kolly, Elke Persohn, et al.
JAMA Oncology|October 7, 2021
Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor-Positive, ERBB2-Negative Advanced Breast Cancer: A Randomized Clinical TrialAntonio Llombart-Cussac, José Manuel Pérez-García, Meritxell Bellet, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2021
Pembrolizumab plus eribulin in hormone-receptor-positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase Ⅱ trialJosé M Pérez-García, Antonio Llombart-Cussac, María G Cortés, et al.
Breast (Edinburgh, Scotland)|June 16, 2024
Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancerSerena Di Cosimo, José Manuel Pérez-García, Meritxell Bellet, et al.
Pageof 55